Rachel Tsunemoto Hislop
Principal, Director of Research at Two Bear Capital
San Diego, California
Overview
Work Experience
Principal, Director of Research
2024 - Current
Principal
2020 - 2024
Two Bear Capital invests in early stage companies with disruptive innovations.
Board Observer
2022 - 2024
Abilita Therapeutics, Inc. is a biotechnology company.
Board Observer
2021 - 2024
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Raised $16,165,350.00 from Two Bear Capital and Two Bear Capital.
Medical Science Liaison
2017 - 2020
Stem Cell and Molecular Biology Researcher
2016 - 2017
Ph.D. researcher working with Dr. Lawrence Goldstein and Dr. Samuel Pfaff
Moores Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center in the San Diego region.
Science Communicator
2013 - 2016
Neuroscience Ph.D. Candidate and Research Associate
2010 - 2016
Neuroscience Ph.D. student (graduated March 2016) working with Dr. Kristin Baldwin (The Scripps Research Institute).
Undergraduate Research Assistant
2008 - 2009
Undergraduate student working with Dr. Li-Huei Tsai.
Summer Research Intern
2007 - 2007
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.